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LOMA LINDA UNIVERSITY

CENTER FOR
CHRISTIAN BIOETHICS

(

Lorna Linda Offers Master of Arts in
Biomedical and Clinical Ethics and Assists
Claremont with Theological Degrees
Beginning in the Fall of 1993, Lorna Linda University will
:lccept qualified students into a course of study leading to the
!1aster of Arts in Biomedical and Clinical Ethics. This new
program is distinctive in at least two ways. First, it integrates
the increasingly separate worlds of biomedical ethics ("issues")
on the one hand and clinical ethics ("cases") on the other.
Second, it explores these matters from Christian points of view
that are neither dogmatic nor doctrinaire.
Since the Fall of 1991, a cooperative arrangement has
existed between Lorna Linda and the School of Theology at
Claremont that has enabled a number of students at the multidenominational seminary to attend classes and receive clinical
experience at Lorna Linda University Medical Center. These
students have worked primarily with M. Jerry Davis, Director
of the office of chaplains at Lorna Linda and David R. Larson,
Co-Director of LLU's Center for Christian Bioethics.
The School of Theology at Claremont is a seminary of the
United Methodist Church with more than four hundred students and twenty-eight faculty who come from more than fifty
different religious traditions and denominations. It offers
courses of study leading to the Master of Divinity and Doctor
of Ministry degrees as well as the Master of Arts and Doctor of
Philosophy degrees.
The programs at Lorna Linda and at Claremont are offered,
governed and granted by institutions of higher learning that
are independent of each other in every way. Co-operative
arrangements have been established, however, that enable
oma Linda students to take selected classes and seminars at
~laremont and for Claremont students to participate in courses
and gain clinical experience at Lorna Linda. This arrangement enables theological students to study on a health sci-

ences campus and for students of the health professions to
study on a theological campus.
It is possible for students in virtually any of Claremont's
programs to spend some time at Lorna Linda. But advanced
students in Claremont's doctoral programs may find it especially useful to take advantage of Lorna Linda's unique opportunities in the areas of biomedical and clinical ethics as well
as pastoral care and clinical ministry.
Further information about the M A program in Biomedical
and Clinical Ethics at Lorna Linda starts on page 2 of this issue.
Information about the Claremont PhD program in Theology
and Personality, with an emphasis in Pastoral Counseling,
including a possible concentration in biomedical and clinical
ethics, starts on page 6. Those who wish additional information about the Lorna Linda program should contact Barton
Rippon, dean of the Graduate School, Lorna Linda University, Lorna Linda, California 92350.
Those who wish more information about the Claremont
programs should contact Allen J. Moore, Dean and Vice
President for Academic Affairs, School of Theology at
Claremont, 1325 North College Avenue, Claremont, CA 917113199.

The Master of Arts at Lorna Linda
The purpose of the course of graduate study leading to a
Master of Arts in Biomedical and Clinical Ethics is to prepare
qualified persons to engage in education, research and service
pertinent to the moral challenges posed by, and experienced
within, the various forms of medical inquiry and therapy.
Upon the completion of this degree, many students will
turn or return to one of the medical professions. Some will
pursue doctoral degrees in biomedical and clinical ethics.
Some will seek advanced degrees in law, social work, ministry,
psychology and related fields. A few may find part-time or fulltime employment as ethics consultants and educators in healthcare institutions or agencies. All will proceed to their next
academic or professional assignments with a thorough understanding of Christian ethical points of view and their pertinence
to medical care, research and education.
The Program in Biomedical and Clinical Ethics is administered by the Faculty of Religion through the Graduate
School. It thereby draws upon resources in many sectors of the
campus. In addition to the five professional schools within
Loma Linda University, and a number of departments within
Loma Linda University Medical Center and Loma Linda
University Children's Hospital, these resources include the
Center for Health Promotion, the Center for Christian Bioethics and the Behavioral Medicine Center.
The Program in Biomedical and Clinical Ethics is supported by the Center for Christian Bioethics in a variety of
ways. The Center's Thompson Library, a constantly growing
specialized collection with approximately 1,500 volumes to
date, aims to become one of the most comprehensive libraries
of materials in biomedical and clinical ethics on the Pacific
Slope. These materials, which are an especially valuable
resource for graduate students, supplement the related holdings in the primary libraries of LLU and nearby institutions.
Admission
In addition to meeting admission requirements for the
Graduate School, the applicant must:
1.
Propose clear personal and professional goals and
ways in which the Program in Biomedical and Clinical Ethics
may facilitate their realization and;
2.
Persuade the admissions committee by previous accomplishments that he or she is able and willing to reach these
goals and to make a distinguished contribution to the field.
Course Requirements
In order to receive the Master of Arts in Biomedical and Clinical
Ethics from Lorna Linda University, each student must:
1.
Complete a minimum of 48 units of course work as
herein specified with an overall grade point average of "B"
or better, with no grade lower than a "C," and with no grade
in a required course lower than a "B-." At least 32 units must
be in approved courses numbered 500-699 or their equivalent.
The required curriculum will be as follows:
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RELE
RELE
RELE
RELE

504
524
548
554

RELE 555
RELE 577
RELE 588
RELE 697
RELE 698

Research Methods
Christian Bioethics
Christian Social Ethics
Clinical Intensive in Biomedical Ethics I
Clinical Intensive in Biomedical Ethics II
Theological Ethics
Types of Ethical Theory
Independent Research

(

Thesis or
Approved Electives

2. Students are able to transfer up to 8 units of approved
courses from other institutions into LLU's Program in Biomedical and Clinical Ethics. Such opportunities are available
at nearby institutions such as La Sierra University, Redlands
University, University of California at Riverside, School of
Theology at Claremont, and Fuller Theological Seminary. In
addition, prior or current students in LLU's other post-baccalaureate degree programs will be able to petition for credit in
this curriculum for up to 12 units of courses completed in their
professional studies that are directly related to biomedical and
clinical ethics. An illustrative list of such courses will be made
available upon request.

continued on page 6

Volume 9, Number 1 (March 1993)
EDITORIAL
ASSOCIATES
Katherine Ching
Richard Utt
Nancy Yuen
PRINTING
LLU Printing Services
SCHOLARS
David R. Larson
Co-Director
Robert D. Orr
Co-Director
Leigh Bishop
Leigh Genesen
Steven Hardin
James Walters
OFFICE SUPERVISOR
Gwendolyn Utt
RESEARCH ASSOCIATE
Duane Covrig

* Executive Committee
Members
FAX: (909) 824-4856
Phone: (909) 824-4956

COUNCIL OF
CONSUL TANTS
Jack W. Provonsha
Founding Chair
'*' Wilber Alexander
Chair
"" James Couperus
Vice-Chair
B. Lyn Behrens
Roy Branson
Brian Bull
Ronald Cafferky
James Crawford
Richard Gingrich
Richard Hart
Darryl Heustis
'* Joyce Hopp
Leanor Boulin Johnson
Miroslav Kis
'* David R. Larson
"" Lawrence Longo
Milton M urrav
'* Robert D. Or;
W. Barton Rippon
Calvin Rock
* Carolyn Thompson
Lois Van Cleve
James Walters
Gerald Winslow
Danielle Wuchenich
"" Thomas Zirkle

Update Volume 9, Number 1

(

Depo-Provera:
Contraceptive Dream or Nightmare?
A Gynecologist's Perspective

Some Catholic Moral Reflections

Elvonne A. Whitney, MD
Assistant Professor
Reproductive Endocrinology
Department of Gynecology and Obstetrics
Loma Linda University
Loma Linda, California

Father leremiah 1. McCarthy, PhD
Academic Dean
St. lohn 's Seminary
Camarillo, California

On October 29, 1992, the US Food and Drug Administration approved the use of Depo-Provera for contraception in
the USA. It has been previously approved for other medical
indications in this country, and has a long history of contraceptive use worldwide. The recent FDA approval has sparked
controversy concerning the use of Depo-Provera for contraception, and about contraception in general. This discussion
addresses the medical aspects of contraception, and DepoProvera specifically.
Unwanted pregnancy is a common problem, and the search
{or an ideal contraceptive continues. Such a contraceptive
would have several important characteristics: ease of use and
compliance, minimal intervention needed by medical personnel, no need for coitus-related action, ease of return to
fertility, protection against sexually-transmitted disease, and
an excellent safety profile. No currently available contraceptive ideally meets all these criteria. However, Depo-Provera
is an important addition to the spectrum of contraceptives
available because of its unique combination of benefits. Data
indicate it is the most effective reversible method of fertility
regulation available today.
Depo-Provera has been used over the past three decades in
over 30 million women in 90 countries, affording opportunity
to study the efficacy and safety of the drug.
Depo-Provera, or depot medroxyprogesterone acetate
(DMPA), is a long-acting injectable progestogen highly effective in preventing pregnancy when given every three months.
Less than 1 percent of women become pregnant during the
first year of using Depo-Provera. This rate is comparable to
sterilization and subdermal implants, and significantly less
than that for oral contraceptives (3%), the IUD (3%), or barrier
methods (generally over 15%). There is no need to comply
with either daily or coitus-related action to prevent pregnancy
with this method. Depo-Provera affords complete contra--eptive privacy to the woman for whom this is important, and
_ :0 medical intervention is necessary to discontinue this method.
Depo-Provera is well-tolerated in extensive clinical trials.
continued on page 4

The approval of Depo-Provera, licensed in October, 1992,
and available in January, 1993, raises a host of ethical considerations. The ethical concerns that have surfaced thus far
seem to fall into two categories: first, the medical risks
associated with the medications and the potential for the
abuse of poor and minority women by state government
agencies; and second, the intrinsic significance of contraception as a personal and public practice, a conversation reflected
in recent Catholic literature.
Perhaps the most attractive feature of this medication
according to the Medical Ethics Advisor, (February 1993), is the
elimination of the fear of missing a daily dose of contraceptive.
At this juncture, critical questions begin to emerge. With the
elmination of this fear, the medications can readily be employed
by governmental agencies who want to enforce restrictions on
unwanted pregnancies as a matter of public policy. This issue
is of serious concern to the staff ethicists involved with the
Hastings Center Project on the effects of long-term contraceptives. While the policy goals may be worthwhile, such as
reducing the incidence of teenage pregnancy, restricting the
reproductive freedom of an abusive mother, or increasing the
likelihood that poor women may avoid the economic burden
of additional children, the ethical concern is the threat to
individual liberty resulting from such policy initiatives.
According to Ellen Moskowitz, a member of the Hastings
Project, "the potential for coercion comes in when, in the zeal
to achieve a policy goal, women are encouraged, manipulated,
or perhaps forced to use these long-term contraceptives"
(Advisor, p. 17). There is evidence for such concerns: Judges
in Texas and California who have made Norplant a condition
for probation in the case of women convicted of child abuse,
the consideration of legislation along similar lines by 13 states
although none has implemented such legislation, and the
decision by Baltimore health officials to provide N orplant in
school-based clinics beginning in January, 1993. As noted, the
Hastings Center has commissioned a two-year study with the
goal of making specific policy recommendations. A key focus
continued on page 4
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Depo Provera: Whitney (Continued from page 3)
The most common side effects are menstrual changes. Most
women experience irregular bleeding patterns, but their frequency decreases with continued use. After one year 57
percent of women reported amenorrhea, which many women
felt was a convenient benefit once they understood that this
indicated no medical problem. With long-term use up to 23
percent of patients elected to discontinue use because of
menstrual changes.
Other side effects include weight gain, headache, nervousness, dizziness, and fatigue. Weight gain averages 5.4lbs.
after one year of use, and up to 161bs. after 6 years of use. The
other side effects mentioned are less frequent, often shortlived, and women usually felt these were minor when compared
to the convenience of using Depo-Provera.
One reason for- the long delay in FDA approval of DepoProvera was a concern about the increased risk of cancer with
long-term use. It is now felt that initial evidence linking its use
to breast cancer in beagle dogs does apply to humans. Longterm human studies and other animal studies have not reached
similar conclusions. The relative risk of breast cancer with
long-term Depo-Provera use has been calculated at 1.21 (95%
C.1. 0.96-1.52), and is not statistically significant. There may
be a small group of women under age 35 already at increased
risk of breast cancer who show an increase in breast cancer
during the first three months of using Depo-Provera. This
increase does not continue with longer use. No increase in
cancer of the ovary or cervix has been documented, and there
is a significant decrease in cancer of the endometrium.
One study in New Zealand showed a decreased bone
density in those women who had used Depo-Provera for five
years compared to control women. This appeared to be
reversible after stopping Depo-Provera, and its significance is
unclear. Further study is needed to determine whether an
increased risk for osteoporosis actually is present with longterm use of Depo-Provera.
Depo-Provera is felt safe to use in breast-feeding mothers
when started six weeks postpartum, and can be started immediately after delivery in non-breast-feeding women. There
have been no reports of congenital defects in the few fetuses
exposed to this contraceptive during pregnancy, and their
growth and development is normal at least through puberty.
Also, because of its high effectiveness, Depo-Provera is an
attractive option for women taking highly teratogenic medications.
Injectable contraceptives such as Depo-Provera do not
permanently affect fertility. While for complete contraceptive
effectiveness injections are needed every twelve weeks,
ovulation and fertility do not immediately return at that point.
However, within one year after the last injection almost 70
percent of women had conceived, and more than 90 percent
within two years. There is no correlation between the length
of use or number of injections and the time to return of
ovulation and fertiltiy.
continued on page 5
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Depo Provera: McCarthy (Continuedfrom page 3)
is the issue of coercion itself. The offer of financial incentiver
to use the medications, or the choice of either jail time d,
probation if the woman agrees to use a contraceptive medication, may be a Hobson's choice, that is, no choice at all. The
specter of the eugenics movement which clouded the movement for birth control in the early part of the century is also
reason for pause. According to Moskowitz, "we do have an
important history in this country to look to control of reproduction to solve intractable social problems"(Advisor, p. 17).

I do not find the benefits of
long-term chemical measures
to be compelling or persuasive.
In order to forestall the use of these medications for
purposes not intended by the manufacturers, clear protocols
for informed consent and careful counseling must be in place.
With teenagers particularly, education about the risks is imperative, because of the danger that increased sexual activity
will escalate the risks of becoming HIV positive. The likelihood that teenagers will avail themselves of condoms is
questionable, and here the discussion joins the debate over
school-based clinics and contraceptives, a much controverte,
public policy matter which I will briefly address at the conclusion.
Ancillary questions also emerge with respect to poor women
who may lack the resources to have the medications either
removed or continued, and the importance of insuring that
physicians do not co-opt the decision-making authority of
women by overriding their concerns with larger public policy
interests.
The ethical issues raised thus far deal with the potential for
abuse, and the appropriate strategy for addressing them appears
to lie in well-formulated protocols insuring informed consent,
freedom from coercion, and careful, thorough counseling.
However, there is another set of concerns that deals with the
substantive issue of contraception itself.
Quite apart from the potential abuses of long-term contraceptives ranging from judicially mandated sterilization, or
racially motivated sterilization, and the threat to womens'
choice and health in developing countries, (i.e., lack of accessibility to skilled medical professionals, lack of follow-up
medical care, and poor antiseptic conditions in "Third World"
clinics), the ethical presupposition underlying contraception
itself is problematic in Catholic moral thought.
Sister Renee Mirkes, writing in the April, 1991, issue of
Ethics and Medics, argues that contraception is morally objectionable because it "deliberately acts against the basic humar
good of procreation, a good that, by God's arrangement, 1
meant to be fostered or respected in every engagement in or
continued on page 5
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Depo Provera: Whitney (Continued from page 4)
Depo-Provera's mechanism of action involves inhibiting
(he secretion of pituitary gonadotropins (FSH, LH) which are
necessary for normal follicular development in the ovary, and
thereby prevents ovulation. The normal endometrial and
cervical changes that occur in preparation for a pregnancy are
also suppressed. These actions prevent pregnancy from occurring, and thus Depo-Provera is not an abortifacient.
The few contraindications for using Depo-Provera include
pregnancy or undiagnosed vaginal bleeding. It is not a good
choice for women who cannot or will not return for injections
every three months, or those unwilling to experience the
menstrual changes associated with Depo-Provera. On the
other hand, it is safe and attractive for many women for whom
estrogen-containing contraceptives are not an option, such as
those with hyperte'nsion, renal or hepatic disease, vascular
disease, uterine fibroids, and endometriosis. Its convenience
makes it an attractive option for institutionalized or mentally
retarded women for whom other contraceptive methods are
difficult. It is of course imperative that safeguards be followed
in the use of Depo-Provera in women who may not be able to
give personal informed consent.
While not for every woman, the Depo-Provera method
offers to many an attractive, affordable, and convenient method
of pregnancy control.
References:
Kleinman RL, Editor. Injectable Contraception Issue, JPPF
.1edical Bulletin. 1992,26: 1-5.
/
Trussell], Kost K. Contraceptive failure in the United States: A
critical review of the literature. Stud Fam Plann. 1987;18:237-83.
WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and depot-medroxyprogesterone acetate: A
Multinational study. Lancet. 1991;338:833-838 .•

Depo Provera: McCarthy (Continued/rom page 4)
abstention from marital intercourse"(p. 2). In other words,
contraception remains morally problematic from a Catholic
perspective because it sunders the linkage between the unitive and procreative meanings of human sexual gesture. This
argument does not rest upon a denial of the empirical fact that
not every act of intercourse is "naturally" open to the possibility of procreation, nor does the Catholic argument contend
that the only valid expression of marital sexual intimacy can
only occur in the context of a clearly procreative intention.
Rather, the point of the Catholic thesis is that basic human
goods, including procreation and marital intimacy, cohere in
an interdependent moral order in which the intrinsic value of
each "bonum" or "human good" is integrally respected. Pursuing this line of thinking, then, attending to natural biological
rhythms to space the size of the family underscores the moral
responsibility of both husband and wife, facilitates communi'ation and awareness of the fertility and reproductive power
.:he spouses possess, and, especially in the form of natural
family planning (not to be confused with an outmoded and
biologically inadequate "rhythm" method), respects the
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woman's biological integrity by avoiding the harmful side
effects of chemical contraception.
This argument has its detractors, of course, even in the
community of Catholic moralists, but it also has its champions,
and space precludes a full elaboration of all of the issues
involved. Nonetheless, I am intrigued by the growing receptivity to the argument especially as the twenty-fifth anniversary of the famous papal encyclical, H umanae Vitae, draws near.
The argument has been vociferously and effectively defended
by Janet Smith in her new book, Humanae Vitae, A Generation
Later, and by Jacquelin Kasun in her volume, The War Against
Population, The Economics and Ideology of Population ' Control.
In conclusion, I find recourse to long-term contraceptive
medications to rest on a flawed premise regarding the control
of human fertility. All parties agree that it is morally responsible to limit the size of the family under certain conditions,
and to avoid pregnancy when it is clearly inappropriate, e.g.,
teenagers and others lacking the emotional, fiscal and personal
maturity to raise a child. The disagreement lies with the
means that are chosen. Measures which radically sunder the
unitive and procreative meaning of human marital intercourse,
are problematic from a Catholic perspective. In addition, use
oflong-term contraceptives to solve complicated public policy
issues such as increased welfare dependency or an escalation
of teenage pregnancy substitutes technical means for a thorough-going moral and human response. I am not naively
suggesting that the answer lies in merely trumpeting the
slogan, "just say no." Rather, I am urging an honest engagement with the real issues that generate poverty and high risk,
irresponsible sexual behavior.
Research into teenage pregnancy, for example, clearly
establishes a strong correlation between poor self-esteem and
the need for personal validation through pregnancy (see the
work by Eunice Kennedy Shriver which supports this contention). Moreover, recourse to contraceptives to address this
problem neglects the important work of cultivating skills for
intimacy which can be taught and learned. Many thoughtful
experts on the problem are rightly concerned that increasing
access to contraceptives sends the wrong message to young
people and contributes to an increase rather than a decrease in
sexual activity. On this score, the recent findings of the Center
for Disease Control in Atlanta detailing the increasingly early
onset of sexual activity, and the report of the New York State
Catholic Conference on sex education deserve close inspection.
The use of long-term contraceptive medications is a refinement that raises ethical concerns endemic to the extensive
conversation in the ethical literature about contraception itself.
Given the proven effectiveness of natural family planning, I do
not find the benefits of long-term chemical measures to be
compelling or persuasive as a means of addressing public
policy or pregnancy issues, and would urge that more attention
be given to natural family planning, to moral education, especially education in skills for intimacy and responsible sexual
behavior, as truly viable alternatives to Depo-Provera.•
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Master of Arts at Lorna Linda University

Comprehensive Examinations

Faculty

Each student must pass five comprehensive written examinations within a single week. These examinations will test
the student's ability to integrate and apply knowledge from
the following areas: (1) philosophical ethics, (2) theological
ethics, (3) social ethics, (4) biomedical ethics, and (5) clinical
ethics. These examinations must be successfully completed
before the student defends a thesis or its approved substitutes.

Wilber Alexander, PhD Michigan State University 1962
Dean, Faculty of Religion;
Professor of Theology and Clinical Ministry
David R. Larson, DivEn School of Theology at Claremont 1973
PhD Claremont Graduate School 1982
Program coordinator; Associate Professor of Christian
Ethics; Co-Director, Center for Christian Bioethics
Leigh Bishop, MD University of Texas, Galveston 1980
MA, University of California, Riverside 1992
Associate Professor of Psychiatry
Robert D. Orr, MD McGill University 1966
Associate Professor of Family Medicine
Director of Clinical Ethics,
Lorna Linda University Medical Center;
Co-Director, Center for Christian Bioethics
Jack W. Provonsha, MD Lorna Linda University 1953
PhD Claremont Graduate School, 1967
Emeritus Professor of Philosophy of Religion
and Christian Ethics
James W. Walters, PhD Claremont Graduate School 1979
Professor of Christian Ethics
Associate Faculty
Roy Branson, PhD Harvard University 1968
Adjunct Professor of Christian Ethics
Charles W. Teel, Jr., PhD Boston University 1972
Adjunct Professor of Christian Ethics
Lois Van Cleve, PhD Claremont Graduate School 1985
Professor of Nursing
Gerald R. Winslow, PhD Graduate Theological Union 1979
Adjunct Professor of Christian Ethics

Clinical Faculty
Dennis deLeon, MD University of Tennessee, Memphis 1985*
Assistant Professor of Family Medicine
Clinical ethicist, Lorna Linda University Medical Center
Leigh B. Genesen, RN, BA Northwestern University 1991"
Instructor in Family Medicine .
Clinical ethicist, Lorna l . . inda University Medical Center
Steven B. Hardin, MD Lorna Linda University 1985
Assistant Professor of Medicine
*Anticipated academic appointment: July 1,1993.
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Thesis or Project
Each student must either prepare a thesis while registered
for RELE 697 and RELE 698 or prepare three major papers of
publishable quality in courses approved as substitutes by the
guidance committee. The student must provide an oral defense
of a thesis or three major papers that analyze specific issues,
cases, dilemmas or themes in biomedical and clinical ethics.
Students must declare whether they intend to write a thesis by
the time they complete 12 quarter units in the program.

The Doctor of Philosophy at
Claremont
The following is taken from the 1991-1993 School of Theology at
Claremont bulletin, pages 38-41.
The PhD program in Theology and Personality at STC is
designed to prepare students for teaching in colleges or
theological schools and for professional leadership in the
church and society. It is a theological degree, a research
degree, and a professional degree. It requires broad theological knowledge and aims at preparing the student for the
competent scholarly development of a special field of study in
the context of the theological disciplines. The student is also
expected to understand the methodological and epistemological presuppositions of the field of concentration and to become
capable of advancing the field through original research.
The degree program emphasizes the professional applicability of the field of research by correlating theoretical and
practical course work and by implementing critical reflection
on the nature of the interdependence of professional theory and
practice, as well as on methods and procedures relevant to it.
STC offers the PhD in Theology and Personality with an
emphasis in either Pastoral Counseling or Religious Education. The program in Counseling is designed to train students
in the theory of research in the behavioral sciences with
emphasis on counseling psychology, and its relationship to
theology. In addition, students may prepare for specialized
ministries in Pastoral Counseling at an advanced level. Such
preparation may require more work than is prescribed in thf'
basic 48 units.
The program in Religious Education integrates theology
with educational theory and practice. Students are expected
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to achieve advanced competence in theological reflection as
well as in educational practice and, through original research,
'i> ~ake a contribution to the development of religious edu)atlOn.
Both programs share a series of doctoral seminars in theology and studies in the human sciences. A thorough knowledge
of the history, literature, major theories, and methods of
research in the field is expected by the completion of the
program.
All students are required to take an English Composition
Skills examination on entrance to the program. Based on the
evaluation of this exam, students may be required to take a
course in English Composition Skills.
Degree Requirements
The PhD program requires General Examinations, language and research requirements, course requirements, an
internship, written and oral qualifying examinations, a dissertation and oral defense. At least two semesters of 12 units
or three semesters of 8 units are required as a residency
requirement. These semesters need not be taken consecutively.
General Examinations
The purpose of the General Examinations is to demonstrate
in five areas:

~ompetence

,7
1. One examination in Systematic Theology
2. One examination in the field of emphasis: either
Pastoral Counseling or Religious Education
3. One examination in the Psychological Sciences
4. Two examinations chosen from the following fields:
a. Biblical Studies
b. History of Christianity and Christian Thought
c. Ethics and Society
d. History of Religions

Each student in the 48-unit PhD program is required to
take at least three examinations during the exam week preceding the beginning of classes in the Fall, before formal study
is begun. If the examinations are not passed, the student may
expect to be assigned remedial work designed to bring the
student to the level of competency presupposed by the PhD
program.
Each student entering under the 72-unit provision must
take at least three examinations upon entrance to the program.
Successful completion of these exams upon entrance may
result in reduction of additional units required above the 48unit program. If three exams are passed, the program will be
reduced by 12 units. If all five exams are passed upon
entrance, the student will begin study under the terms of the
'-8-unit PhD program .
. ,' Each student who is admitted with an MA in an area other
than theological studies and is requried to complete 40 units of
additional course work in theological studies, must take and
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pass three examinations before entering the final 48 units of
the PhD program. The remaining two must be passed before
registering for the final 24 units of PhD study.
Language and Research Requirements
Students must demonstrate a reading knowledge of either
French or German. A second language or a research method
appropriate to the student's dissertation is also required. One
ofthese language or research tools must be completed prior to
beginning the final 24 units of PhD study.
Course Requirements
A minimum of 48 units of course work must be completed
at STC, and more units may be required. The course requirements are as follows:
Emphasis in Counseling

Theology (12)
Courses in one or two of the following areas:
Systematic Theology
Biblical Studies

Theological Ethics
Church History

Cognate Field (8)
Courses in an approved cognate field related to counseling,
such as clinical psychology, developmental psychology, etc.
The cognate field is ordinarily taken at Claremont
Graduate School or with approval at the Department of
Pastoral Services, Loma Linda Medical School.
Pastoral Counseling (20)
Courses distributed across supervised counseling (8
units credit; 8 units audit), History, Psychopathology,
and Psychotherapeutic Theory and Method. Supervised
Counseling provides actual counseling experience under
the supervision of STC professors at the Clinebell
Institute.
Departmental Seminars (8)
Courses that are (1) relevant both to Pastoral Counseling
and Religious Education, (2) integrative of theory and
practice in theology and the human sciences, and (3)
addressing common themes, including Psychology of
Religion, Human Development, Practical Theology,
Pastoral Assessment, and Research Methods.
At least one course is to be a Theological Methods course.
Students must take at least one-quarter of approved Clinical Pastoral Education (CPE) prior to admission or during their
PhD program. No unit credit is awarded for this requirement.
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Emphasis in Education
Theology (12)
Courses in one or two of the following areas:

on Academic Procedures. This Committee then recommends
the student to the faculty for advancement to Candidacy for
the PhD degree.

(

Dissertation
Systematic Theology
Biblical Studies

Theological Ethics
Church History

Cognate Field (8)
Courses in an approved cognate field related to Education.
The cognate field is ordinarily taken at Claremont Graduate
School.
Religious Education (20)
Courses distributed across pedagogical theory, history, and
social psychological theory.
Department Seminars (8)
Courses that are (1) relevant both to pastoral Counseling
and Religious Education, (2) integrative of theory and
practice in theology and the human sciences, and (3)
addressing common themes, including Psychology of Religion, Human Development, Practical Theology, Pastoral
Assessment, and Research Methods.

At least one course is to be a Theological Methods course.
Internship:
At least one semester in full-time advanced internship or
field-based research in Religious Education.
Qualifying Exams
Qualifying Exams are taken when the student has completed all course work requirements, the research tool expectations, and the Internship/Residency. The qualifying
exams cover five areas, following the areas of the course work
requirements. Five written examinations, each four hours in
length, are required. An oral examination will be conducted by
the student's Guidance Committee. (See Academic Policy
Handbook for specific requirements.)
Dissertation Proposal
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At the conclusion of the qualifying examinations, the
student will present a dissertation proposal to the examining
committee. After the proposal has been approved by the
Guidance Committee, it will be submitted to the Committee

CENTER FOR CHRISTIAN BIOETHICS
LOMA LINDA UNIVERSITY

Lorna Linda, CA 92350

The student is required to present an acceptable dissertation
based upon independent research. The dissertation must
demonstrate the student's capacity to relate resources from at
least one of the classical theological disciplines (Bible, History
of Christianity, Theology, or Ethics) and the resources from
Counseling or Education.
The PhD candidate must successfully complete the final
oral examination related to the dissertation research. The final
oral examination will be conducted by the Guidance Committee
plus an outside examiner representing the faculty as a whole.
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